Foregut carcinoids: a clinical and biochemical analysis

Area of Science:

• Oncology
• Endocrinology
• Gastroenterology

Background:

• Gastrointestinal foregut carcinoids are rare, comprising 3% to 6% of all carcinoids.
• The rarity of these tumors hinders comparative analyses between subtypes.
• This study aimed to compare gastric, duodenal, and pancreatic carcinoid subtypes.

Purpose of the Study:

• To compare the hormonal and clinical characteristics of gastric, duodenal, and pancreatic carcinoids.
• To investigate differences in hormone levels, clinical presentation, treatment, and survival rates.
• To determine if the organ of origin influences the behavior of foregut carcinoids.

Main Methods:

• A prospective database of approximately 750 carcinoid patients was reviewed.
• 104 patients with gastric (33), duodenal (17), or pancreatic (54) carcinoids were selected for analysis.
• Patients were compared based on hormone levels, clinical course, treatment, and survival data.

Main Results:

• Duodenal carcinoids had significantly lower serotoninergic hormone levels (urine 5-hydroxyindoleacetic acid) than gastric and pancreatic carcinoids (5 ± 1 vs. 16 ± 5 and 47 ± 12, respectively; P = .03).
• Pancreatic carcinoids presented at a more advanced stage, with 87% having distant metastases compared to 42% for gastric and 20% for duodenal.
• Pancreatic carcinoids had significantly worse outcomes, with a 10-year survival rate of 10% compared to 59% for gastric and 58% for duodenal carcinoids (P = .003).

Conclusions:

• Pancreatic carcinoids exhibit higher serotoninergic hormone production, advanced stage at presentation, and poorer outcomes than other foregut carcinoids.
• The organ of origin is a critical factor influencing hormonal activity and clinical trajectory in patients with foregut carcinoids.
• These findings highlight the distinct biological behavior and clinical implications of different foregut carcinoid subtypes.